These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. [Current status and future perspective of peptide vaccine for biliary tract cancer]. Aruga A Nihon Rinsho; 2015 Mar; 73 Suppl 3():823-6. PubMed ID: 25857143 [No Abstract] [Full Text] [Related]
51. Current immunotherapeutic strategies in renal cell carcinoma. Amato RJ Surg Oncol Clin N Am; 2007 Oct; 16(4):975-86, xi-xii. PubMed ID: 18022554 [TBL] [Abstract][Full Text] [Related]
52. Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma. Everson RG; Graner MW; Gromeier M; Vredenburgh JJ; Desjardins A; Reardon DA; Friedman HS; Friedman AH; Bigner DD; Sampson JH Expert Rev Anticancer Ther; 2008 May; 8(5):717-32. PubMed ID: 18471045 [TBL] [Abstract][Full Text] [Related]
53. [WT1 Class I Peptide/WT1 Class II Peptide Pulsed Dendritic Cell Therapy Efficacy in 60 Patients with a Wide Range of Advanced Cancers]. Kato Y Gan To Kagaku Ryoho; 2016 Oct; 43(10):1252-1255. PubMed ID: 27760951 [TBL] [Abstract][Full Text] [Related]
54. Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going? Parmiani G; Castelli C; Dalerba P; Mortarini R; Rivoltini L; Marincola FM; Anichini A J Natl Cancer Inst; 2002 Jun; 94(11):805-18. PubMed ID: 12048268 [TBL] [Abstract][Full Text] [Related]
55. Next-generation dendritic cell-based vaccines for leukemia patients. Hoffmann JM; Schmitt M; Ni M; Schmitt A Immunotherapy; 2017 Jan; 9(2):173-181. PubMed ID: 28128712 [TBL] [Abstract][Full Text] [Related]
56. Peptide vaccines against cancer, infectious diseases, and conception. Naz RK; Dabir P Front Biosci; 2007 Jan; 12():1833-44. PubMed ID: 17127424 [TBL] [Abstract][Full Text] [Related]
57. Vaccines and immune checkpoint inhibitors: a promising combination strategy in gastrointestinal cancers. Bashir B; Flickinger JC; Snook AE Immunotherapy; 2021 May; 13(7):561-564. PubMed ID: 33724866 [TBL] [Abstract][Full Text] [Related]
58. Gene signature in melanoma associated with clinical activity: a potential clue to unlock cancer immunotherapy. Gajewski TF; Louahed J; Brichard VG Cancer J; 2010; 16(4):399-403. PubMed ID: 20693853 [TBL] [Abstract][Full Text] [Related]
59. [WT1 peptide cancer vaccine]. Sugiyama H Nihon Rinsho; 2017 Feb; 75(2):263-269. PubMed ID: 30562862 [TBL] [Abstract][Full Text] [Related]
60. The expanding role of immunotherapy. Martin-Liberal J; Ochoa de Olza M; Hierro C; Gros A; Rodon J; Tabernero J Cancer Treat Rev; 2017 Mar; 54():74-86. PubMed ID: 28231560 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]